跳至主要内容
临床试验/NL-OMON49213
NL-OMON49213招募中不适用

Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of<br>pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC

Radboud Universitair Medisch Centrum0 个研究点目标入组 465 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
465

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - 18 years and older
  • - clinical suspicion of pancreatic cancer
  • - written (signed and dated) informed consent

排除标准

  • - Previous treatment for pancreatic cancer (e.g. chemotherapy, radiotherapy,
  • surgery, ablation therapy)
  • - Concomitant malignancies, except for adequately treated basocellular
  • carcinoma of the skin or in situ carcinoma of the cervix uteri. Subjects with
  • prior malignancies must be disease-free for at least 5 years
  • - Contra-indications to undergo CT (due to e.g. extreme claustrophobia,
  • untreatable contrast allergy, renal function impairment)
  • - Contra-indications to undergo MRI (due to e.g. claustrophobia, untreatable
  • contrast allergy, or not MRI compatible medical devices)
  • - Insufficient command of the Dutch language to be able to understand the
  • patient information or fill in the questionnaires
  • - Pregnancy

研究者

相似试验